Skip to Main Content

Paper Details

Cost-Effectiveness Analysis of a HMGA2 Prognostic Test for Acute Myeloid Leukemia in a Canadian Setting.
Appl Health Econ Health Policy
2
2019
Author NameAffiliation
Guy SauvageauUniversite de Montreal
Guy SauvageauResearch Centre, Maisonneuve-Rosemont Hospital
Guy SauvageauMaisonneuve-Rosemont Hospital
Guy SauvageauUniversite de Montreal
Marie-Jos??e H??bertUniversite de Montreal
Marie-Jos??e H??bertResearch Centre, Maisonneuve-Rosemont Hospital
Marie-Jos??e H??bertMaisonneuve-Rosemont Hospital
Marie-Jos??e H??bertUniversite de Montreal
  • 1 - 8

Datasets

Release 1.2